Complement activation, specifically factors C3, C4, C3a, Factor-H and Properdin, are associated with increased incident metabolic syndrome (28); and complement activation was related to adverse pregnancy outcomes, such as intrauterine growth retardation and GDM (24, 29). This evidence concerns the gene C3 and gestational diabetes.